Download
s11096-021-01260-z.pdf 1,10MB
WeightNameValue
1000 Titel
  • Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis
1000 Autor/in
  1. Colarossi, Giorgia |
  2. Maffulli, Nicola |
  3. Trivellas, Andromahi |
  4. Schnöring, Heike |
  5. Hatam, Nima |
  6. Tingart, Markus |
  7. Migliorini, Filippo |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-03-28
1000 Erschienen in
1000 Quellenangabe
  • 43(4):825-838
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11096-021-01260-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352815/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background Argatroban, lepirudin, desirudin, bivalirudin, and danaparoid are commonly used to manage heparin-induced thrombocytopenia related complications. However, the most suitable drug for this condition still remains controversial. Aim of the review This Bayesian network meta-analysis study compared the most common anticoagulant drugs used in the management of heparin-induced thrombocytopenia. Method All clinical trials comparing two or more anticoagulant therapies for suspected or confirmed heparin-induced thrombocytopenia were considered for inclusion. Studies concerning the use of heparins or oral anticoagulants were not considered. Data concerning hospitalisation length, thromboembolic, major, and minor haemorrhagic events, and mortality rate were collected. The network analyses were made through the STATA routine for Bayesian hierarchical random-effects model analysis with standardised mean difference (SMD) and log odd ratio (LOR) effect measures. Results Data from a total of 4338 patients were analysed. The overall mean age was 62.31 ± 6.6 years old. Hospitalization length was considerably shorter in favour of the argatroban group (SMD: - 1.70). Argatroban evidenced the lowest rate of major (LOR: - 1.51) and minor (LOR: - 0.57) haemorrhagic events. Argatroban demonstrated the lowest rate of thromboembolic events (LOR: 0.62), and mortality rate (LOR: - 1.16). Conclusion Argatroban performed better overall for selected patients with HIT. Argatroban demonstrated the shortest hospitalization, and lowest rate of haemorrhages, thromboembolisms, and mortality compared to bivalirudin, lepirudin, desirudin, and danaparoid.
1000 Sacherschließung
lokal Anticoagulants/adverse effects [MeSH]
lokal Arginine/analogs
lokal Thromboembolism
lokal Humans [MeSH]
lokal Review Article
lokal Middle Aged [MeSH]
lokal Bayes Theorem [MeSH]
lokal Bleeding
lokal Heparin/adverse effects [MeSH]
lokal Network Meta-Analysis [MeSH]
lokal Pipecolic Acids/therapeutic use [MeSH]
lokal Mortality
lokal Anticoagulants
lokal Thrombocytopenia/drug therapy [MeSH]
lokal Thrombocytopenia/chemically induced [MeSH]
lokal Heparin-induced thrombocytopenia
lokal Sulfonamides [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/Q29sYXJvc3NpLCBHaW9yZ2lh|https://frl.publisso.de/adhoc/uri/TWFmZnVsbGksIE5pY29sYQ==|https://frl.publisso.de/adhoc/uri/VHJpdmVsbGFzLCBBbmRyb21haGk=|https://frl.publisso.de/adhoc/uri/U2NobsO2cmluZywgSGVpa2U=|https://frl.publisso.de/adhoc/uri/SGF0YW0sIE5pbWE=|https://frl.publisso.de/adhoc/uri/VGluZ2FydCwgTWFya3Vz|https://orcid.org/0000-0001-7220-1221
1000 Hinweis
  • DeepGreen-ID: ddb08c344bc64f9782becc759c5ab173 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6444825.rdf
1000 Erstellt am 2023-04-27T14:35:23.406+0200
1000 Erstellt von 322
1000 beschreibt frl:6444825
1000 Zuletzt bearbeitet 2023-10-20T14:03:48.617+0200
1000 Objekt bearb. Fri Oct 20 14:03:48 CEST 2023
1000 Vgl. frl:6444825
1000 Oai Id
  1. oai:frl.publisso.de:frl:6444825 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source